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Introduction: Although anaerobic bacteria have been detected in abundance in the
CF airways, the impact their presence and abundance has on lung function and
inﬂammation is unclear.
Objectives: To investigate the relationship between aerobic and anaerobic bacterial
colony counts (CC), lung clearance index (LCI), FEV1 and systemic inﬂammation
in clinically stable CF child and adult patients.
Methods: Sputum was collected from CF patients and community composition and
bacterial abundance was analysed using extended aerobic and anaerobic culture. All
subjects completed spirometry and multiple breath washout using 0.2% SF6 and
a modiﬁed Innocor™ device to obtain LCI. Blood C-reactive protein, (CRP) was
measured by turbidimetric immunoassay. Spearman’s rank correlation coefﬁcient
was used to assess relationships.
Results: Aerobic and anaerobic bacteria were detected in sputum samples from
all 29 CF patients studied. A signiﬁcant negative correlation between total anaer-
obic CC and LCI (r = −0.54; p = 0.002) was observed. The relationship between
total anaerobic CC and FEV1% predicted (r = 0.29; p = 0.13) was not signiﬁcant.
Similarly, the relationship between total aerobic CC, LCI (r = −0.32; p = 0.09)
and FEV1% predicted (r = 0.27; p = 0.16) was not signiﬁcant. In a subgroup of
patients (15/29; 52%), a signiﬁcant negative correlation was observed between total
anaerobic CC and CRP levels (r = −0.56, p = 0.03).
Conclusions: A higher CC of anaerobic bacteria resulted in a better LCI and lower
CRP, indicating that a lower load of anaerobic bacteria may reﬂect microbiota
disruption and disease progression in the CF lung.
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Objectives: To assess the use of Lung Clearance Index (LCI) as a tool for
monitoring pulmonary response to ivacaftor therapy.
Methods: Ivacaftor therapy became standard in NI in 2013 for CF patients with
one G551D-CFTR allele, positive sweat chloride and/or evidence of sino-pulmonary
disease. Data were collected retrospectively on all adults and children on ivacaftor
in NI. LCI measurements had been recorded pre-treatment, at 1 and 6 months on
treatment, along with FEV1.
Results: 22 patients were eligible for inclusion, 15 adults and 8 children. Data
were complete on 7 children and 7 adults at baseline and at 1 month. Due to lack
of sufﬁcient data, analysis was not carried out in the adults at 6 months. Mean
baseline LCI: adults 11.15 (range 8–15.8); children 9.07 (range 6.54–10.8). Mean
LCI after 1 month of treatment: adults 10.93 (range 8–13.77); children 7.68 (range
6.57–8.76). Mean LCI after 6 months of treatment: children 7.8 (range 6.12–10.73).
Drop in LCI correlated with increase in FEV1. Many of the children had normal
or near normal % predicted FEV1 with a mean FEV1 of 84.1% (71–105%) at
baseline, 101.5 (72–150%) at 1 month and 96.3% (66–126%) at 6 months.
Conclusion: Mean LCI improved in adults and children after 1 month of ivacaftor
therapy and was sustained in children at 6 months. LCI may be a useful tool for
monitoring the effectiveness of ivacaftor therapy especially in those with normal
FEV1.
